King International Investment Overview
- Year Founded
-
2001

- Status
-
Public
- Employees
-
13

- Stock Symbol
-
00928

- Investments
-
1
King International Investment General Information
Description
King International Investment Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business, Money lending business and sales of liquor business. It generates maximum revenue from the sales of liquor business segment. Geographically, it derives a majority of revenue from PRC. The group is a provider of genetic testing and health data analysis services.
Contact Information
Website
www.kinginternational.hkCorporate Office
- Room 2001, 20/F, Two Chinachem Exchange Square
- 338 King's Road, North Point
- Hong Kong
- Hong Kong
Corporate Office
- Room 2001, 20/F, Two Chinachem Exchange Square
- 338 King's Road, North Point
- Hong Kong
- Hong Kong
King International Investment Stock Performance
As of 14-Feb-2025, King International Investment’s current market cap is $7.84M with 1.85B shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$7.84M | 1.85B | 1.91M |
King International Investment Financials Summary
As of 30-Sep-2024, King International Investment has a trailing 12-month revenue of $24M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 22,797 | 18,415 | 5,152 | 17,697 |
Revenue | 23,990 | 29,864 | 28,556 | 11,930 |
EBITDA | 2,535 | 3,536 | (3,374) | (4,512) |
Net Income | 1,605 | 2,022 | (3,214) | (4,426) |
Total Assets | 43,311 | 42,948 | 33,665 | 38,703 |
Total Debt | 687 | 729 | 857 | 54 |
King International Investment Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
King International Investment Signals
King International Investment Investments (1)
King International Investment’s most recent deal was a Secondary Transaction - Private with Guangzhou Manrui Biotech Company for . The deal was made on 05-Aug-2016.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Guangzhou Manrui Biotech Company | 05-Aug-2016 | Secondary Transaction - Private | Drug Discovery |
King International Investment FAQs
-
When was King International Investment founded?
King International Investment was founded in 2001.
-
Where is King International Investment headquartered?
King International Investment is headquartered in Hong Kong, Hong Kong.
-
What is the size of King International Investment?
King International Investment has 13 total employees.
-
What industry is King International Investment in?
King International Investment’s primary industry is Holding Companies.
-
Is King International Investment a private or public company?
King International Investment is a Public company.
-
What is King International Investment’s stock symbol?
The ticker symbol for King International Investment is 00928.
-
What is the current market cap of King International Investment?
The current market capitalization of King International Investment is $7.84M.
-
What is King International Investment’s current revenue?
The trailing twelve month revenue for King International Investment is $24M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »